any talk of restricting medicare will surely bring crys of "death panels" from right wingers but how can we allow situations like this, that could bankrupt medicare for all, to continue without taking cost benefit into account?
-----------------------------------------------------------
Dendreon Corp. (DNDN)âs prostate cancer drug Provenge should be covered by the U.S. government for use in older men, regulators said.
The $93,000 treatment regimen is âreasonable and necessaryâ for men with advanced, castrate-resistant prostate tumors who have minimal or no symptoms of the disease, the Centers for Medicare & Medicaid Services said today.
Note this well - this drug does not cure prostate cancer.
Studies supporting Provenge approval showed the drug helped men with prostate cancer live a median of 4.1 months longer.
http://www.philstockworld.com/2011/03/31/the-poster-child-for-medical-hell/
-----------------------------------------------------------
Dendreon Corp. (DNDN)âs prostate cancer drug Provenge should be covered by the U.S. government for use in older men, regulators said.
The $93,000 treatment regimen is âreasonable and necessaryâ for men with advanced, castrate-resistant prostate tumors who have minimal or no symptoms of the disease, the Centers for Medicare & Medicaid Services said today.
Note this well - this drug does not cure prostate cancer.
Studies supporting Provenge approval showed the drug helped men with prostate cancer live a median of 4.1 months longer.
http://www.philstockworld.com/2011/03/31/the-poster-child-for-medical-hell/